Patient Guide to Adriblastina Injection (Doxorubicin)

Overview

Adriblastina Injection is a medication used to treat various types of cancer. As a patient, it's essential to understand the benefits and potential risks associated with this treatment. This guide will walk you through the uses, mechanism of action, dosage, side effects, precautions, and frequently asked questions related to Adriblastina Injection.

Uses

Adriblastina Injection, containing 2mg/ml of doxorubicin (plain), is manufactured by Pfizer Ltd. This medication is used to treat various types of cancer, including:

• Breast cancer
• Ovarian cancer
• Bladder cancer
• Lung cancer
• Hodgkin's lymphoma
• Non-Hodgkin's lymphoma
• Soft tissue sarcoma

Mechanism of Action

Adriblastina Injection works by interfering with the growth of cancer cells. Doxorubicin, the active ingredient, binds to DNA and prevents the cancer cells from reproducing, thereby slowing down or stopping the growth of the tumor.

Dosage

The dosage of Adriblastina Injection is determined by your healthcare provider based on your specific condition, medical history, and other factors. The typical dosage range for this medication is:

• 30-75 mg/m2 administered intravenously over 3-10 minutes every 21 days
• The maximum cumulative dose should not exceed 500 mg/m2

Side Effects

As with any medication, Adriblastina Injection can cause side effects. Some common side effects include:

• Nausea and vomiting
• Hair loss
• Diarrhea
• Fatigue
• Increased risk of infection (due to low white blood cell count)
• Cardiotoxicity (heart damage)

In rare cases, more severe side effects may occur, such as:

• Anaphylaxis (severe allergic reaction)
• Severe bleeding or bruising
• Liver damage
• Kidney damage

Precautions

Before receiving Adriblastina Injection, inform your healthcare provider if you have any of the following conditions:

• Heart problems (e.g., heart failure, coronary artery disease)
• Liver or kidney disease
• Low white blood cell count
• Recent radiation therapy
• Recent chemotherapy
• Pregnancy or breastfeeding

FAQs

Q: What are the risks of Adriblastina Injection? A: Adriblastina Injection can cause side effects, such as nausea, hair loss, and increased risk of infection. In rare cases, more severe side effects may occur, such as cardiotoxicity, anaphylaxis, or organ damage.

Q: How often will I receive Adriblastina Injection? A: The dosage and frequency of Adriblastina Injection will be determined by your healthcare provider based on your specific condition and medical history.

Q: Can I take Adriblastina Injection if I'm pregnant or breastfeeding? A: It's not recommended to take Adriblastina Injection if you're pregnant or breastfeeding. Inform your healthcare provider if you're planning to conceive or are currently breastfeeding.

Remember, it's essential to follow your healthcare provider's instructions and attend all scheduled appointments to ensure the best possible outcome. If you have any questions or concerns, don't hesitate to reach out to your healthcare provider or a member of their team.